Publications by authors named "A Elbehiry"
() is a Gram-negative, spiral-shaped bacterium that colonizes the gastric epithelium and is associated with a range of gastrointestinal disorders, exhibiting a global prevalence of approximately 50%. Despite the availability of treatment options, frequently reemerges and demonstrates increasing antibiotic resistance, which diminishes the efficacy of conventional therapies. Consequently, it is imperative to explore non-antibiotic treatment alternatives to mitigate the inappropriate use of antibiotics.
View Article and Find Full Text PDFKlebsiella pneumoniae (K. pneumoniae) is a member of the ESKAPE group and is responsible for severe community and healthcare-associated infections. Certain Klebsiella species have very similar phenotypes, which presents a challenge in identifying K.
View Article and Find Full Text PDFBackground: Management of uncontained medial proximal tibial defects during primary total knee arthroplasty (TKA) can be challenging, especially for defects ≥ 10 mm in depth. This study sought to assess the outcomes of autogenous structural bone grafts to address these defects.
Materials And Methods: In this prospective study, patients with uncontained medial proximal tibial defects ≥ 10 mm in depth undergoing TKA were managed by autogenous structural bone grafts fixed by screws and were followed up for at least 36 months.
Article Synopsis
- Alzheimer's disease is a major cause of dementia, especially in people over 60, with cases expected to rise significantly by 2050, highlighting the urgent need for effective treatments.
- Lecanemab, a monoclonal antibody that targets amyloid-beta plaques, has shown promise in slowing Alzheimer's progression, supported by positive clinical trial results and ongoing research to enhance understanding of its effects.
- A systematic review and meta-analysis of lecanemab at a dosage of 10 mg/kg revealed significant cognitive improvements in Alzheimer's patients, while also noting potential safety concerns that necessitate careful monitoring in clinical settings.
The genus Enterobacter belongs to the ESKAPE group, which includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. This group is characterized by the development of resistance to various antibiotics. In recent years, Enterobacter cloacae (E.
View Article and Find Full Text PDF